These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 7540486)

  • 41. Antibody to stratum corneum (antikeratin antibody) and antiperinuclear factor: markers for progressive rheumatoid arthritis.
    Kurki P; von Essen R; Kaarela K; Isomäki H; Palosuo T; Aho K
    Scand J Rheumatol; 1997; 26(5):346-9. PubMed ID: 9385344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies.
    Meyer O; Tauxe F; Fabregas D; Gabay C; Goycochea M; Haim T; Elias A; Kahn MF
    Clin Exp Rheumatol; 1993; 11(5):473-8. PubMed ID: 7506130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antikeratin antibodies in rheumatoid arthritis].
    Larsen HL
    Ugeskr Laeger; 1991 May; 153(22):1567-71. PubMed ID: 1711726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti-perinuclear antibodies in the diagnosis and prognosis of rheumatoid polyarthritis].
    Youinou P; Le Goff P; Miossec P; L'Hostis D; Pennec Y; Schwarzberg C; Ferrec C
    Rev Rhum Mal Osteoartic; 1983 May; 50(6):441-6. PubMed ID: 6351234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection.
    Cojocaru M; Cojocaru IM; Iacob SA
    Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis.
    Hayem G; Chazerain P; Combe B; Elias A; Haim T; Nicaise P; Benali K; Eliaou JF; Kahn MF; Sany J; Meyer O
    J Rheumatol; 1999 Jan; 26(1):7-13. PubMed ID: 9918234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An immunogenetic study of older age onset rheumatoid arthritis.
    Terkeltaub R; Décary F; Esdaile J
    J Rheumatol; 1984 Apr; 11(2):147-9. PubMed ID: 6610048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunologic diagnosis of rheumatoid arthritis].
    Corvetta A; Montroni M; Gabrielli A; Danieli MG; Danieli G
    Recenti Prog Med; 1986 Jun; 77(6):305-15. PubMed ID: 3489964
    [No Abstract]   [Full Text] [Related]  

  • 50. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis.
    Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E
    J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiplexed immunoassay for detection of rheumatoid factors by FIDISTM technology.
    Abreu I; Laroche P; Bastos A; Issert V; Cruz M; Nero P; Fonseca JE; Branco J; Machado Caetano JA
    Ann N Y Acad Sci; 2005 Jun; 1050():357-63. PubMed ID: 16014552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.
    Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G
    Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
    Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical relevance of antikeratin antibodies in rheumatoid arthritis.
    Miossec P; Youinou P; Le Goff P; Moineau MP
    Clin Rheumatol; 1982 Sep; 1(3):185-9. PubMed ID: 6205812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiperinuclear factor and antikeratin antibody in the diagnosis of rheumatoid arthritis: comment on the article by Kim and Weisman.
    Alnigenis MN; Barland P
    Arthritis Rheum; 2000 Nov; 43(11):2617. PubMed ID: 11083295
    [No Abstract]   [Full Text] [Related]  

  • 58. Specificity of antiperinuclear factor for rheumatoid arthritis in rheumatoid factor-positive sera.
    Berthelot JM; Maugars Y; Audrain M; Youinou P; Prost A
    Br J Rheumatol; 1995 Aug; 34(8):716-20. PubMed ID: 7551653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The antiperinuclear factor and antikeratin antibody systems.
    Youinou P; Serre G
    Int Arch Allergy Immunol; 1995 Aug; 107(4):508-18. PubMed ID: 7542514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT; Lohse AW
    Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.